ConductScience.org, home

Gene · 429

NIH grants3,413

NIH grants whose papers are about the gene, through NIH's grant-paper links.

141 to 160 of 3,413

Download this page as JSON
GrantTitleASCL1 papersNewest fiscal year
R37CA230617Hormone signaling and translation control in advanced prostate cancer22025
R37CA269990Mechanisms by which LSD1 Promotes Neuroendocrine Differentiation and Small Cell Lung Cancer22025
R50CA221836Statistical modeling to support population and translational cancer research22025
RF1AG056306Assessing cellular aging in old and rejuvenated neurons from Alzheimer patients22025
T32AG000222Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease22025
T32CA009207Investigational Cancer Therapeutics Training Program (ICTTP)22025
T32DE007057Tissue Engineering and Regeneration22025
T32DK007713Clinical and Laboratory Research Training for Gastrointestinal Surgeons22025
T32EY007031Vision Training Grant22025
T32EY026590Translational Vision Research Training at UCSD22025
T32GM133351Pathways in Biological Sciences Training Program22025
T32GM135141Rutgers Biotechnology Training Program22025
T32GM136577Medical Scientist Training Program22025
T32GM141323Medical Scientist Training Program (T32 NRSA Training Grant)22025
T32GM145440Medical Scientist Training Program22025
T32HG000044Institutional Training Grant in Genome Science22025
U01AG072579Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease22025
U01CA253383Understanding the molecular mechanism of a protein-recycling complex in small cell lung cancer treatment resistance.22025
U54CA274492The Center for Tumor-Immune Systems Biology at MSKCC22025
UL1TR002345Washington University Institute of Clinical and Translational Sciences22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/429/grants?page=8